Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Circulating tumour cell dynamics as a predictor for treatment response and...

Prof Wolfgang Janni - Ulm University, Ulm, Germany

Circulating tumour cell dynamics as a predictor for treatment response and prognosis in metastatic breast cancer patients ( Prof Wolfgang Janni - Ulm University, Ulm, Germany )

ETNK1 mutations in atypical chronic myeloid leukaemia can be reverted with...

Dr Diletta Fontana - The University of Milano-Bicocca, Milan, Italy

ETNK1 mutations in atypical chronic myeloid leukaemia can be reverted with phosphoethanolamine ( Dr Diletta Fontana - The University of Milano-Bicocca, Milan, Italy )

Latest data for managing ALK NSCLC patients

Prof Myung-Ju Ahn - Samsung Medical Center, Seoul, South Korea

Latest data for managing ALK NSCLC patients ( Prof Myung-Ju Ahn - Samsung Medical Center, Seoul, South Korea )

Pregnancy outcomes in breast cancer survivors; meta-analysis

Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy

Pregnancy outcomes in breast cancer survivors; meta-analysis ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )

ASCENT: A phase II trial of induction, consolidation and maintenance in...

Prof Andrzej Jakubowiak - University of Chicago, Chicago, USA

ASCENT: A phase II trial of induction, consolidation and maintenance in subjects with high risk smouldering MM ( Prof Andrzej Jakubowiak - University of Chicago, Chicago, USA )

Peripheral blood CD26 leukaemia stem cell monitoring in CML during TKI treatment

Prof Monica Bocchia - University of Siena, Siena, Italy

Peripheral blood CD26 leukaemia stem cell monitoring in CML during TKI treatment ( Prof Monica Bocchia - University of Siena, Siena, Italy )

Decitabine plus ipilimumab in r/r MDS/AML in the post-BMT or transplant naïve...

Dr Jacqueline Garcia - Dana-Farber Cancer Institute, Boston, USA

Decitabine plus ipilimumab in r/r MDS/AML in the post-BMT or transplant naïve settings ( Dr Jacqueline Garcia - Dana-Farber Cancer Institute, Boston, USA )

Treating acute leukaemias of ambiguous lineage

Dr Lindsey Montefiori - Department of Pathology, St. Jude Children's Research...

Treating acute leukaemias of ambiguous lineage ( Dr Lindsey Montefiori - Department of Pathology, St. Jude Children's Research Hospital, USA )

First-in-class STAMP inhibitor asciminib in patients with CML harbouring the...

Dr Jorge Cortes - Augusta University, Augusta, USA

First-in-class STAMP inhibitor asciminib in patients with CML harbouring the T315I mutation ( Dr Jorge Cortes - Augusta University, Augusta, USA )

Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D)...

Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA

Weekly carfilzomib, lenalidomide, dexamethasone and daratumumab (wKRd-D) combination therapy in newly diagnosed multiple myeloma ( Prof Ola Landgren - Memorial Sloan Kettering Cancer Center, New York City, USA )

Analysis of the B-HOLISTIC study and importance of relapsed/refractory Hodgkin...

Prof Mark Hertzberg - Prince of Wales Hospital, Sydney, Australia

$Analysis of the B-HOLISTIC study and importance of relapsed/refractory Hodgkin lymphoma real world evidence data ( Prof Mark Hertzberg - Prince of Wales Hospital, Sydney, Australia )$

Five year update of ECHELON-1 for classical Hodgkin lymphoma

Dr Otavio Baiocchi - Centro Especializado em Oncologia, São Paulo, Brazil

Five year update of ECHELON-1 for classical Hodgkin lymphoma ( Dr Otavio Baiocchi - Centro Especializado em Oncologia, São Paulo, Brazil )

More from ecancer